Bradley H. Goldberg
Experienced in Hairy Cell Leukemia (HCL)

Dr. Bradley H. Goldberg

Hematology | Oncology
450 Lakeville Road, Entrance B, 
Lake Success, NY 
On Staff At
Offers Telehealth
Experienced in Hairy Cell Leukemia (HCL)
450 Lakeville Road, Entrance B, 
Lake Success, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Bradley Goldberg is a Hematologist and an Oncologist in Lake Success, New York. Dr. Goldberg is rated as an Experienced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Acute Promyelocytic Leukemia, Childhood Acute Myeloid Leukemia, Acute Myeloblastic Leukemia with Maturation, Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration.

His clinical research consists of participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
SUNY Downstate Medical Center
Residency
Hofstra North Shore-Lij School Of Medicine
Specialties
Hematology
Oncology
Licenses
Internal Medicine in NY
Board Certifications
American Board Of Internal Medicine
American Board Of Internal Medicine/Hematology
American Board Of Internal Medicine/Medical Oncology
Hospital Affiliations
Hofstra/Northwell School Of Medicine/Nursing
Long Island Jewish Medical Center
North Shore University Hospital
Cancer Institute
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
CenterLight Healthcare
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health First
  • HMO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MetLife
  • PPO
Northwell Health
  • INSURANCE PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

Northwell Health Center for Advanced Medicine, RJ Zuckerberg Cancer Center
450 Lakeville Road, Entrance B, Lake Success, NY 11042

Additional Areas of Focus

Dr. Goldberg has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Thrombocytopenia
Leukemia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3, Randomized, Open-label, Multicenter Study Comparing Ponatinib Versus Imatinib, Administered in Combination With Reduced-Intensity Chemotherapy, in Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
A Phase 3, Randomized, Open-label, Multicenter Study Comparing Ponatinib Versus Imatinib, Administered in Combination With Reduced-Intensity Chemotherapy, in Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
Enrollment Status: Active_not_recruiting
Publish Date: November 26, 2025
Intervention Type: Drug
Study Drugs: Ponatinib, Imatinib, Vincristine, Dexamethasone, Cytarabine, Methotrexate, Prednisone
Study Phase: Phase 3
A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (a Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL
A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (a Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL
Enrollment Status: Suspended
Publish Date: September 05, 2025
Intervention Type: Biological, Drug, Procedure, Other
Study Drugs: Allopurinol, Cytarabine, Daunorubicin Hydrochloride, Vincristine Sulfate, Dexamethasone, Pegylated L-Asparaginase, Methotrexate, Cyclophosphamide, Mercaptopurine, Rituximab, Doxorubicin, Thioguanine, Inotuzumab
Study Phase: Phase 3
A Phase I Study to Evaluate the Pharmacokinetics and Safety of Belantamab Mafodotin Monotherapy in Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM) Who Have Normal and Varying Degrees of Impaired Renal Function (DREAMM 12)
A Phase I Study to Evaluate the Pharmacokinetics and Safety of Belantamab Mafodotin Monotherapy in Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM) Who Have Normal and Varying Degrees of Impaired Renal Function (DREAMM 12)
Enrollment Status: Active_not_recruiting
Publish Date: May 23, 2025
Intervention Type: Drug
Study Drug: Belantamab Mafodotin
Study Phase: Phase 1
View 2 Less Clinical Trials
Similar Doctors
Elite in Hairy Cell Leukemia (HCL)
Dr. Jae H. Park
Hematology Oncology | Hematology | Oncology
Elite in Hairy Cell Leukemia (HCL)
Dr. Jae H. Park
Hematology Oncology | Hematology | Oncology

Memorial Hematology Lymphoma Group

1275 York Ave, 
New York, NY 
 (13.4 miles away)
212-639-2000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jae Park is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Park is rated as an Elite provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Hairy Cell Leukemia (HCL), Acute Lymphoblastic Leukemia (ALL), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.

Elite in Hairy Cell Leukemia (HCL)
Dr. Omar I. Abdel-Wahab
Oncology
Elite in Hairy Cell Leukemia (HCL)
Dr. Omar I. Abdel-Wahab
Oncology

Memorial Hematology Lymphoma Group

1275 York Ave, 
New York, NY 
 (13.4 miles away)
212-639-2000
Languages Spoken:
English

Omar Abdel-Wahab is an Oncologist in New York, New York. Dr. Abdel-Wahab is rated as an Elite provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Reticulohistiocytoma, Hairy Cell Leukemia (HCL), Leukemia, Rosai-Dorfman Disease, and Bone Marrow Aspiration.

Douglas E. Gladstone
Elite in Hairy Cell Leukemia (HCL)
Dr. Douglas E. Gladstone
Oncology | Transplant Surgery
Elite in Hairy Cell Leukemia (HCL)
Dr. Douglas E. Gladstone
Oncology | Transplant Surgery

Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center

450 Lakeville Road, Entrance B, 
Lake Success, NY 
 (0.1 miles away)
516-734-8900
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Douglas Gladstone is a Transplant Surgeon in Lake Success, New York. Dr. Gladstone is rated as a Distinguished provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Hairy Cell Leukemia (HCL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Goldberg's expertise for a condition
ConditionClose
    View All 63 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile